ELAB News | Roxom Stocks

1 BTC

=

- USD

Loading market data...

EL

Mkt Cap

$2.5M

Volume

12.44K

Next Earnings

November 13th

Chart Financials Earnings News About Insider Filings

PMGC Holdings Inc. (Nasdaq: ELAB) Secures Five-Year Royalty Stream from Elevai Skincare Sale Under Executed Payment Agreement with Longevity Health HoldingsPMGC Holdings Inc. (Nasdaq: ELAB) has executed a payment agreement with Longevity Health Holdings to convert its 5% net sales royalty from the January 2025 Elevai Skincare divestiture into scheduled monthly cash payments through August 2031. The agreement covers the 2025 royalty of $94,937 and all future royalty payments, with installments of $10,000 per month starting October 2026, interest accruing at WSJ Prime plus 1%, and mandatory prepayments triggered by capital events.GlobeNewswire Inc. · Sep 18, 2026

PMGC Holdings Announces Term Sheet with Orbit2Orbit for NorthStrive Biosciences to Launch a Spaceflight Study of Its Myostatin and Activin A Assets, EL-22 and EL-32, Targeting Microgravity-Induced Muscle LossPMGC Holdings has entered into a non-binding term sheet with Australia-based Orbit2Orbit to conduct a spaceflight study evaluating NorthStrive Biosciences' muscle-preservation therapeutics (EL-22 and EL-32) in microgravity. The multi-part relationship includes a Mice2Space research collaboration, a U.S. aerospace manufacturing partnership with A&B Aerospace, and a planned CAD $200,000 strategic investment by PMGC in Orbit2Orbit ahead of its proposed Canadian Securities Exchange listing.GlobeNewswire Inc. · Aug 25, 2026

PMGC Holdings Confirms Compliance with Nasdaq’s New $5 Million Market Value of Listed Securities RequirementPMGC Holdings Inc. (Nasdaq: ELAB) confirmed compliance with Nasdaq's new Market Value of Listed Securities requirement with 8,095,835 shares outstanding as of July 29, 2026. The company is correcting inaccurate share count data from third-party providers and reported significant growth with total assets reaching $26.0 million (up 102% from year-end 2025) and cash of $14.4 million. The company recently completed the acquisition of A&B Aerospace, Inc. in May 2026.GlobeNewswire Inc. · Jul 29, 2026

NorthStrive Biosciences to Advance EL-22 Manufacturing Characterization with Quantitative FACS Analysis of Latent Myostatin Antigen ExpressionNorthStrive Biosciences announced plans to initiate an independent flow cytometry (FACS) analysis program to characterize EL-22, an engineered Lactobacillus casei-based therapeutic candidate designed to preserve muscle during weight loss treatments. The study will quantify latent myostatin antigen expression on NorthStrive-manufactured cells and establish comparability against material previously manufactured by MOA Life Plus Co. Ltd., strengthening product identity and manufacturing consistency for future IND-enabling development.GlobeNewswire Inc. · Jul 10, 2026

NorthStrive Biosciences Announces Positive Results from Phase III of AI-Driven Drug Discovery Program with Yuva BiosciencesNorthStrive Biosciences announced positive Phase III results from its AI-driven drug discovery program with Yuva Biosciences. Four small-molecule candidates identified by Yuva's MitoNova™ AI platform demonstrated statistically significant increases in ANT1 protein expression in primary human skeletal muscle cells, with dose-dependent induction ranging from +29% to +50%. The candidates will advance to confirmatory testing in more mature muscle models.GlobeNewswire Inc. · Jul 1, 2026

PMGC Holdings Signs Non-Binding Letter of Intent to Acquire Majority Stake in U.S.-Based Precision Machining Manufacturing Company Serving Aerospace, Space, Defense, and Semiconductor MarketsPMGC Holdings Inc. (NASDAQ: ELAB) announced a non-binding letter of intent to acquire a 76% controlling stake in an Arizona-based precision machining and contract manufacturing company for cash. The target company generated approximately $5.46 million in revenue and $1.05 million in EBITDA for fiscal year 2025, with over 20% adjusted EBITDA margins. The acquisition aligns with PMGC's roll-up strategy in U.S.-based manufacturing and would expand capabilities in aerospace, defense, and semiconductor markets. The transaction is subject to due diligence, financial audit completion, and customary closing conditions, with expected closure before Q4 2026.Benzinga · Jun 1, 2026

NorthStrive® Companies Inc. Co-Advises on Acquisition of A&B Aerospace, Inc.NorthStrive Companies Inc. served as co-advisor to PMGC Holdings Inc. in its successful acquisition of A&B Aerospace, Inc., a California-based precision aerospace manufacturing company founded in 1948. The transaction closed on May 12, 2026, and involved the purchase of 100% of A&B Aerospace's shares on a cash-free, debt-free basis. NorthStrive provided financial advisory, due diligence coordination, legal execution, and post-close transition services.Benzinga · May 18, 2026

PMGC Grabs Precision Parts Maker Serving Boeing, HoneywellPMGC Holdings (NASDAQ: ELAB) acquired California-based A&B Aerospace for $4.5 million, marking its fifth acquisition in 12 months. A&B Aerospace, founded in 1948, manufactures high-tolerance aerospace and defense parts for customers including Boeing and Honeywell. The acquisition supports PMGC's strategy to build an AS9100D-certified CNC machining platform. PMGC shares rose 10.87% in premarket trading following the announcement.Benzinga · May 13, 2026

PMGC Holdings (NASDAQ: ELAB) Acquires A&B Aerospace, Inc.PMGC Holdings Inc. (NASDAQ: ELAB) has acquired A&B Aerospace, Inc., a precision machining and aerospace manufacturing company, for a base purchase price of $4.5 million. This marks PMGC's fifth acquisition in the past twelve months as part of its roll-up strategy in U.S.-based precision manufacturing. A&B Aerospace generated approximately $5.0M in revenue and $610K in management-adjusted EBITDA over the trailing twelve months ended February 28, 2026, and serves Tier 1 customers including Boeing, Honeywell, and Moog.Benzinga · May 13, 2026

Univest Securities, LLC Announces a $40 Million Equity Line Facility for its Client PMGC Holdings, Inc. (NASDAQ: ELAB)Univest Securities closed a $40 million equity line facility for PMGC Holdings Inc. (NASDAQ: ELAB), a diversified holding company focused on precision manufacturing roll-ups. The facility includes an initial tranche of $10 million, with shares offered privately under Regulation D and subject to SEC registration for resale.GlobeNewswire Inc. · Apr 21, 2026

EL

ELABPMGC Holdings Inc. Common Stock

ELAB

Pay with—

Available Balance0.00

Your PositionYou don't own any ELAB yet.

Related Tickers

Earnings